SCHEMBL25190447

SCHEMBL25190447

CN1CCN(CC(=O)N(O)Cc2ccc(Nc3ccc(-c4ccc(C(C)(C)C)cc4)cc3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ SERPINE1 P05121 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ALPL P05186 1/20 0.37
▸ PTBP1 P26599 1/20 0.37
▸ KIF11 P52732 1/20 0.37
▸ CDK1 P06493 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25188470 0.97 RORC (0.42) RORCALDH1A1MAPTKDM4ERAB9A
SCHEMBL25183908 0.89 POLB (0.41) RORCALDH1A1MAPTKDM4ERAB9A
SCHEMBL25199979 0.88 LMNA (0.44) ALDH1A1KDM4ERAB9AHDAC1LMNA
SCHEMBL25190439 0.87 ALDH1A1 (0.42) ALDH1A1KDM4ECHKA
SCHEMBL25187819 0.87 HDAC1 (0.43) ALDH1A1MAPTHDAC1HDAC8HDAC6
SCHEMBL25200167 0.86 MAPT (0.44) RORCALDH1A1MAPTKDM4EHDAC1
SCHEMBL25194243 0.86 IKBKE (0.47) RAB9AHDAC1HDAC8HDAC6LMNA
SCHEMBL25190319 0.86 ATM (0.38) ALDH1A1KDM4ERAB9AHDAC1HDAC8
SCHEMBL25192112 0.85 RORC (0.41) RORCALDH1A1MAPTKDM4ERAB9A
SCHEMBL25190412 0.85 SIGMAR1 (0.45) RORCALDH1A1MAPTRAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 — — CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 RORC 4449/4885ALDH1A1 395/4885MAPT 4384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback